Recruiting
Acute lymphocytic leukaemia recurrent+1
RecruitingInvestigationalNo placebo
Study on CD19+ Lymphoid Disease Using Genetically Modified T Cells for Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma
InvestigationalNo placebo
- Disease:Acute lymphocytic leukaemia recurrentNon-Hodgkin's lymphoma refractory
- Substances:T Lymphocytes Transduced With A Rv-Sfg.cd19.Cd28.4-1Bbzeta Retroviral Vector
Countries:
Germany
Germany- Participants:0–17 years · 18–64 years · 65+ years
- Substances:T Lymphocytes Transduced With A Rv-Sfg.cd19.Cd28.4-1Bbzeta Retroviral Vector
- Sponsor:Universitaetsklinikum Heidelberg AöR




